Arkolith/Insider Trading/INO/Form 4

Weiner David B.

DirectorINOVIO PHARMACEUTICALS, INC. (INO) · full profile →Form 4 · filed Mar 13, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2023Sell(S)6K$1.15$7K910K
Mar 11, 2023Option exercise(M)12K——916K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 11, 2023Option exercise(M)12K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001055726-23-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML